Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 85 clinical trials
featured
REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

REHAB-HF: A Trial of Rehabilitation Therapy in Older Acute Heart Failure Patients

  • 80 views
  • 08 Nov, 2020
  • 1 location
Short Stay Unit vs Hospitalization in Acute Heart Failure

The majority of the over one million annual AHF hospitalizations originate from the emergency department. Admitting and re-admitting lower risk AHF patients who don't need prolonged hospitalization may increase their risk for poor outcomes and decrease their quality of life: Safe alternatives to hospitalization from the ED are needed. We …

nitroglycerin
loop diuretic
diuretics
  • 196 views
  • 28 Jan, 2021
  • 12 locations
Digoxin Short Term Treatment Assessment Randomized Trial in AHF

> Whether digoxin is efficient and safe in short term treatment of acute heart failure is a question that should be studied.

  • 3 views
  • 24 Jan, 2021
  • 2 locations
Insulin Dextrose Infusion vs Nebulized Salbutamol vs Combination of Salbutamol and Insulin Dextrose in Acute Hyperkalemia

Hyperkalemia is a common electrolyte disorder, especially among patients with chronic kidney disease, diabetes mellitus, or heart failure. Globally, the reported incidence of hyperkalemia varies from 1.1 to 10 per 100 hospitalizations, depending on the patient cohort and comorbidities. Hyperkalemia is a potentially life-threatening electrolyte disturbance that can be fatal …

  • 1 views
  • 03 Feb, 2021
  • 15 locations
Acute Heart Failure - COngestion Discharge Evaluation

Acute heart failure (AHF) is a major public health problem, associated with a 40% risk of death or re-hospitalisation at 3 months. This risk is significantly increased by insufficient

pulmonary congestion
natriuretic peptide
congestion
  • 0 views
  • 29 Jan, 2021
  • 1 location
Acute Heart Failure - COngestion Repeated Evaluation (AHF-CORE)

ultrasound) at the beginning and at the end of hospitalization for acute heart failure that are more strongly associated with the risk of all cause death or rehospitalization for acute heart failure within 3

congestion
  • 7 views
  • 27 Jan, 2021
  • 3 locations
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation

. The main objective of the AHF-CODE preserved study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are

  • 0 views
  • 02 Feb, 2021
  • 1 location
Acute Heart Failure With Reduced Ejection Fraction - COngestion Discharge Evaluation

> The main objective of the AHF-CODE study is to identify congestion markers (clinical, biological and ultrasound) at the end of hospitalization for acute heart failure that are associated with the risk

  • 0 views
  • 30 Jan, 2021
  • 1 location
Adrecizumab Dose Escalation Safety and Tolerability Evaluation (ADESTE)

for HAM8101 (Adrecizumab) in AHF, using a dose escalating design. Acute Heart Failure (AHF), both as deterioration of chronic stable condition or "de novo" onset constitutes a major indication

  • 5 views
  • 17 Mar, 2021
  • 2 locations
Treatment With the Ketone Body 3-hydroxybutyrate in Patients With Cardiogenic Shock

Background Cardiogenic shock is a life-threatening state of acute heart failure with severely depressed blood pressure and organ perfusion. The 30-day mortality is reported as high as 50%. To

  • 0 views
  • 27 Jan, 2021
  • 1 location